Bio-Sourcing and Zerion Pharma join forces to develop first HER2 oral monoclonal antibody
Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti HER2, antibody trastuzimab, for treatment of breast cancer
























